Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 06, 2015 titled "Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA.". Investor Presentation
Cadila Healthcare Ltd has submitted to BSE a copy of Investor Presentation May 2015. Clarifies on News Item
With reference to news item in the Economic Times dated May 21, 2015 regarding "Cadila eyes Claris Arm for Rs. 3400Cr". Cadila Healthcare Ltd has Clarified to BSE as under :"News item in the Economic Times dated May 21, 2015 is a speculative in nature and it is our Company's policy not to respond to any such speculative news items. As a responsible listed Company, we inform stock exchanges of all information which is required to be disclosed,... Code of Conduct of Fair Disclosure
Cadila Healthcare Ltd has informed BSE regarding Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015. Result of Postal Ballot
Cadila Healthcare Ltd has informed BSE that the members of the Company have passed the resolutions, by way of Postal Ballot, under Clause 35A. Clause 20
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a copy of Statement of Appropriation as per Clause 20 of the Listing Agreement for the Financial Year ended March 31, 2015. Results Press Release
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a copy of Results Press Release for the period ended March 31, 2015. Fixes Book Closure for Dividend & AGM
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 03, 2015 to August 12, 2015 (both days inclusive) for the purpose of Payment of Dividend & 20th Annual General Meeting (AGM) of the Company to be held on August 12, 2015. Date from which the dividend is payable: On or after August 17, 2015. Auditors Report for March 31, 2015
Cadila Healthcare Ltd has informed BSE that has submitted to BSE a Copy of the Auditors Report for the period ended March 31, 2015. Board recommends Dividend
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2015, inter alia, have recommended a dividend of Rs. 12/- (@ 240%) per equity share on 204,748,520 equity shares of Rs. 5/- on March 31, 2015.